Closed
NONE
Award Notice
RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)
- NAICS
- 541714
- Solicitation number
- 75A50126C00010
- Place of performance
- Washington, DC
- Estimated value
- Up to $340.9M
- Closed
- Oct 2, 2026
- Posted
- Sep 30, 2026
Description
This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Track this market for the recompete
This opportunity has closed. Follow NAICS 541714 and we'll alert you when the follow-on contract posts.